These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 16191712)

  • 41. Vaccination with recombinant FimH fused with flagellin enhances cellular and humoral immunity against urinary tract infection in mice.
    Asadi Karam MR; Oloomi M; Mahdavi M; Habibi M; Bouzari S
    Vaccine; 2013 Feb; 31(8):1210-6. PubMed ID: 23306365
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Colibacillosis in poultry: unravelling the molecular basis of virulence of avian pathogenic Escherichia coli in their natural hosts.
    Dziva F; Stevens MP
    Avian Pathol; 2008 Aug; 37(4):355-66. PubMed ID: 18622850
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Secretory expression of K88 (F4) fimbrial adhesin FaeG by recombinant Lactococcus lactis for oral vaccination and its protective immune response in mice.
    Hu CX; Xu ZR; Li WF; Niu D; Lu P; Fu LL
    Biotechnol Lett; 2009 Jul; 31(7):991-7. PubMed ID: 19277476
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Cholera toxin improves the F4(K88)-specific immune response following oral immunization of pigs with recombinant FaeG.
    Verdonck F; Snoeck V; Goddeeris BM; Cox E
    Vet Immunol Immunopathol; 2005 Jan; 103(1-2):21-9. PubMed ID: 15626459
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The chicken as a natural model for extraintestinal infections caused by avian pathogenic Escherichia coli (APEC).
    Antão EM; Glodde S; Li G; Sharifi R; Homeier T; Laturnus C; Diehl I; Bethe A; Philipp HC; Preisinger R; Wieler LH; Ewers C
    Microb Pathog; 2008; 45(5-6):361-9. PubMed ID: 18848980
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [The study for the immuno-protection of E. coli O157:H7 outer membrane protein].
    Zhang Y; Lu SQ; Zhang YZ; Zhao BX; Xu JG
    Zhonghua Yi Xue Za Zhi; 2004 Jan; 84(1):58-62. PubMed ID: 14990161
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The polymeric stability of the Escherichia coli F4 (K88) fimbriae enhances its mucosal immunogenicity following oral immunization.
    Verdonck F; Joensuu JJ; Stuyven E; De Meyer J; Muilu M; Pirhonen M; Goddeeris BM; Mast J; Niklander-Teeri V; Cox E
    Vaccine; 2008 Oct; 26(45):5728-35. PubMed ID: 18762221
    [TBL] [Abstract][Full Text] [Related]  

  • 48. A cyclophosphamide-sensitive cell compartment is essential for homologous protection conferred by licensed vaccines for the control of avian pathogenic Escherichia coli in chickens.
    Sadeyen JR; Kaiser P; Stevens MP; Dziva F
    Vaccine; 2015 Jul; 33(31):3624-7. PubMed ID: 26087298
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Split immune response after oral vaccination of mice with recombinant Escherichia coli Nissle 1917 expressing fimbrial adhesin K88.
    Remer KA; Bartrow M; Roeger B; Moll H; Sonnenborn U; Oelschlaeger TA
    Int J Med Microbiol; 2009 Nov; 299(7):467-78. PubMed ID: 19467927
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Virulence factors of Escherichia coli, with emphasis on avian pathogenic isolates].
    Landman WJ; Cornelissen RA
    Tijdschr Diergeneeskd; 2006 Nov; 131(22):822-30. PubMed ID: 17263016
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antibody responses against avian reovirus nonstructural protein sigmaNS in experimentally virus-infected chickens monitored by a monoclonal antibody capture enzyme-linked immunosorbent assay.
    Chen PN; Liu HJ; Shien JH; Lee LH
    Res Vet Sci; 2004 Jun; 76(3):219-25. PubMed ID: 15046956
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Protective immune response of bacterially-derived recombinant FaeG in piglets.
    Yahong H; Liang W; Pan A; Zhou Z; Wang Q; Huang C; Chen J; Zhang D
    J Microbiol; 2006 Oct; 44(5):548-55. PubMed ID: 17082749
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Construction and phase I clinical evaluation of the safety and immunogenicity of a candidate enterotoxigenic Escherichia coli vaccine strain expressing colonization factor antigen CFA/I.
    Turner AK; Beavis JC; Stephens JC; Greenwood J; Gewert C; Thomas N; Deary A; Casula G; Daley A; Kelly P; Randall R; Darsley MJ
    Infect Immun; 2006 Feb; 74(2):1062-71. PubMed ID: 16428753
    [TBL] [Abstract][Full Text] [Related]  

  • 54. A recombinant multi-antigen vaccine with broad protection potential against avian pathogenic Escherichia coli.
    Van Goor A; Stromberg ZR; Mellata M
    PLoS One; 2017; 12(8):e0183929. PubMed ID: 28837660
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of spray Escherichia coli vaccine on the immunity of poultry.
    Fernandes Filho T; Fávaro C; Ingberman M; Beirão BC; Inoue A; Gomes L; Caron LF
    Avian Dis; 2013 Sep; 57(3):671-6. PubMed ID: 24283136
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Induction of specific immune responses in piglets by intramuscular immunization with fimbrial adhesin FaeG expressed in Lactococcus lactis.
    Liu S; Li Y; Xu Z
    Res Vet Sci; 2013 Aug; 95(1):130-6. PubMed ID: 23540979
    [TBL] [Abstract][Full Text] [Related]  

  • 57. In vitro and in vivo characterization of avian Escherichia coli. III. Immunization.
    Rosenberger JK; Fries PA; Cloud SS
    Avian Dis; 1985; 29(4):1108-17. PubMed ID: 3914273
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Exploiting bacterial outer membrane vesicles as a cross-protective vaccine candidate against avian pathogenic Escherichia coli (APEC).
    Hu R; Li J; Zhao Y; Lin H; Liang L; Wang M; Liu H; Min Y; Gao Y; Yang M
    Microb Cell Fact; 2020 Jun; 19(1):119. PubMed ID: 32493405
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Nonspecific innate immunity against Escherichia coli infection in chickens induced by vaccine strains of Newcastle disease virus.
    Huang HJ; Matsumoto M
    Avian Dis; 2000; 44(4):790-6. PubMed ID: 11195632
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Systemic immunization with conserved pilus-associated adhesins protects against mucosal infections.
    Palaszynski S; Pinkner J; Leath S; Barren P; Auguste CG; Burlein J; Hultgren S; Langermann S
    Dev Biol Stand; 1998; 92():117-22. PubMed ID: 9554264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.